Dashboard
Manage Tickers

ALVO Alvotech

Nasdaq alvotech.com


$ 5.09 $ -0.17 (-3.25 %)    

Thursday, 20-Nov-2025 15:58:55 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 585.41 $ -14.20 (-2.37 %)
DIA $ 458.06 $ -3.66 (-0.79 %)
SPY $ 652.30 $ -10.10 (-1.52 %)
TLT $ 89.25 $ 0.35 (0.39 %)
GLD $ 374.78 $ -0.11 (-0.03 %)
$ 5.06
$ 5.39
$ 5.09 x 197
$ 5.11 x 314
$ 5.06 - $ 5.40
$ 4.70 - $ 13.70
647,667
na
1.53B
$ 0.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

alvotech-and-advanz-pharma-announce-eea-approval-for-gobivaz-biosimilar-to-simponi-strengthening-access-to-high-quality-biologic-medicines
Alvotech And Advanz Pharma Announce EEA Ap...
11/20/2025 09:08:11

ubs-maintains-buy-on-alvotech-lowers-price-target-to-10
UBS Maintains Buy on Alvotech, Lowers Pric...
11/18/2025 19:00:32

UBS analyst Ashwani Verma maintains Alvotech (NASDAQ:ALVO) with a Buy and lowers the price target from $13 to $10.

ardent-health-kindercare-learning-ibotta-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Ardent Health, KinderCare Learning, Ibotta...
11/13/2025 13:29:13

alvotech-lowers-fy2025-sales-guidance-from-600000m-700000m-to-570000m-600000m-vs-592949m-est
Alvotech Lowers FY2025 Sales Guidance from...
11/12/2025 22:01:42

Alvotech (NASDAQ:ALVO) lowers FY2025 sales outlook from $600.000 million-$700.000 million to $570.000 million-$600.000 million ...

alvotech-q3-eps-002-inline-sales-113744m-miss-117203m-estimate
Alvotech Q3 EPS $(0.02), Inline, Sales $11...
11/12/2025 22:00:31

Alvotech (NASDAQ:ALVO) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is unchang...

earnings-scheduled-for-november-12-2025
Earnings Scheduled For November 12, 2025
11/12/2025 11:11:28

uncovering-potential-alvotechs-earnings-preview
Uncovering Potential: Alvotech's Earnings ...
11/11/2025 16:02:38

alvotech-secures-legal-victory-in-uk-supporting-manufacturing-freedom-and-market-access-for-avt06-biosimilar-to-eylea
Alvotech Secures Legal Victory In UK Suppo...
11/10/2025 09:36:22

alvotech-and-advanz-pharma-receive-uk-mhra-approval-for-gobivaz-biosimilar-across-multiple-indications
Alvotech And Advanz Pharma Receive UK MHRA...
11/06/2025 14:15:00

Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for pa...

this-kimberly-clark-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday
This Kimberly-Clark Analyst Is No Longer B...
11/04/2025 11:56:53

top-3-health-care-stocks-which-could-rescue-your-portfolio-in-november
Top 3 Health Care Stocks Which Could Rescu...
11/04/2025 11:24:48

deutsche-bank-downgrades-alvotech-to-hold-lowers-price-target-to-8
Deutsche Bank Downgrades Alvotech to Hold,...
11/04/2025 10:54:03

Deutsche Bank analyst Niall Alexander downgrades Alvotech (NASDAQ:ALVO) from Buy to Hold and lowers the price target from $1...

gold-edges-higher-ism-manufacturing-pmi-falls-in-october
Gold Edges Higher; ISM Manufacturing PMI F...
11/03/2025 19:23:45

alvotech-shares-plunge-33-after-fda-flags-issues
Alvotech Shares Plunge 33% After FDA Flags...
11/03/2025 18:17:22

Alvotech shares decline after the FDA issues a complete response letter for its Simponi biosimilar, leading to a lower 2025 rev...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
11/03/2025 17:05:47

kimberly-clark-vertex-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Kimberly-Clark, Vertex And Other Big Stock...
11/03/2025 13:14:55

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
11/03/2025 12:05:47

why-lucas-gc-shares-are-trading-higher-by-over-36-here-are-20-stocks-moving-premarket
Why Lucas GC Shares Are Trading Higher By ...
11/03/2025 10:09:58

reported-sunday-alvotech-announces-fda-complete-response-letter-for-avt05-biosimilar-application-and-revises-2025-outlook-amid-facility-related-investments
Reported Sunday, Alvotech Announces FDA Co...
11/03/2025 07:52:08

morgan-stanley-upgrades-alvotech-to-overweight-announces-14-price-target
Morgan Stanley Upgrades Alvotech to Overwe...
10/14/2025 12:54:56

Morgan Stanley analyst Thibault Boutherin upgrades Alvotech (NASDAQ:ALVO) from Equal-Weight to Overweight and announces $14 ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION